Alcoholism and Schizophrenia: Effects of Clozapine

PHASE4TerminatedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 1999

Study Completion Date

January 31, 2004

Conditions
SchizophreniaDual DiagnosisSchizoaffective DisorderPsychotic DisorderSubstance AbuseAlcohol Abuse
Interventions
DRUG

Clozapine versus typical (conventional) and atypical antipsychotic medications

Trial Locations (1)

02130

Commonwealth Research Center, Jamaica Plain

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

Commonwealth Research Center, Massachusetts

OTHER

collaborator

Novartis

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER